Raymond James Trust N.A. Moderna, Inc. Transaction History

Raymond James Trust N.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$101.21 - $166.61 $60,928 - $100,299	602 Added 30.28%	2,590 $307,000
Q1 2024 Apr 24, 2024	BUY	$85.37 - $115.44 $169,715 - $229,494	1,988 New	1,988 $211,000
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $200,776 - $291,589	1,480 New	1,480 $228,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $112,928 - $209,899	-893 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$225.82 - $368.51 $530,225 - $865,261	-2,348 Reduced 72.45%	893 $227,000
Q3 2021 Oct 18, 2021	BUY	$221.9 - $484.47 $719,177 - $1.57 Million	3,241 New	3,241 $1.25 Million

913

236M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.